Hyderabad (Telangana) [India], June 4 (ANI): Biological E. Limited, a Hyderabad-based pharmaceutical and vaccines company, on Saturday, announced that its Corbevax COVID-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous COVID-19 booster dose for individuals aged 18 years and above after six months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for restricted use in an emergency situation.
Hyderabad (Telangana) [India], May 16 (ANI): The price of COVID-19 vaccine Corbevax has been reduced to Rs 250 a dose from its earlier Rs 840, said Biological E Limited (BE) on Monday.
New Delhi [India], May 10 (ANI): Over three crore children in the age group of 12-14 years have been administered the first dose of the COVID-19 vaccine, said Union Health Minister Mansukh Mandaviya said on Tuesday.
New Delhi [India], March 9 (ANI): Hyderabad-based pharmaceutical company Biological E has applied for Emergency Use Authorisation (EUA) for its COVID-19 vaccine Corbevax for the 5-12 year age group, official sources said on Wednesday.
Washington [US], February 23 (ANI): Ambassador of India to the United States, Taranjit Singh Sandhu on Tuesday said cutting-edge technology and research leadership of the US and capabilities of India, the world's largest vaccine manufacturer, can be combined for producing affordable vaccines.
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions, official sources said.
Houston [US], December 29 (ANI): Texas Children's Hospital and Baylor College of Medicine announced on Tuesday (local time) that Corbevax, a protein sub-unit COVID-19 vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General of India (DCGI) to launch in India with other underserved countries to follow.
Hyderabad (Telangana) [India], October 26 (ANI): To provide further momentum to the ongoing nationwide vaccination drive, the COVID-19 vaccine Corbevax vaccine will be rolled out by end of November, Biological E Limited said on Monday.
New Delhi [India], October 14 (ANI): Biological E will submit final data on COVID-19 vaccine Corbevax till November end, informed Government sources on Thursday.
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
